|
Increasing Condom Use in People at Risk for HIV Infection Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Increasing Condom Use in People at Risk for HIV Infection conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Increasing Condom Use in People at Risk for HIV Infection Clinical research trials and Increasing Condom Use in People at Risk for HIV Infection healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Increasing Condom Use in People at Risk for HIV Infection. Increasing Condom Use in People at Risk for HIV Infection Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Increasing Condom Use in People at Risk for HIV Infection clinical trial. Test subjects typically receive the most effective healthcare possible for their Increasing Condom Use in People at Risk for HIV Infection condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Increasing Condom Use in People at Risk for HIV Infection  Increasing Condom Use in People at Risk for HIV Infection
Increasing Condom Use in People at Risk for HIV Infection
For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This study will evaluate a new program designed to increase condom use in both women and men.
Details: As heterosexual HIV transmission increases, effective behavioral interventions to increase condom use are needed. Interventions should be low cost and accessible to large segments of the at-risk population. This study will evaluate the efficacy of a behavioral intervention designed to increase condom use in at-risk, heterosexually active women and men. The intervention is computer-delivered and will be provided in health care settings. The study will also examine additional psychosocial mediators of condom use by testing the predictive efficacy of the Multifaceted Model of HIV Risk. Participants will be recruited from four health clinic sites that serve local ethnic minority communities. The participants will be randomly assigned to either an individualized intervention designed to increase condom use or to an HIV information comparison group. All participants will receive comparable group-specific informational materials at study entry and at Months 2 and 4. Participants in the intervention group will receive individualized feedback and specially tailored manuals. Participants in the HIV information comparison group will receive general HIV information feedback and the best available informational manual. Assessments for both groups will be conducted at study entry and at Months 6, 12, and 18. At study entry, participants will complete paper and pencil questionnaires requiring about 30 minutes. There will also be computer question sessions at study entry and at Months 2 and 4. Participants will be asked about condom use, contraceptive use, risk behaviors, STD history, and personal relationships. Telephone follow-ups at Months 6, 12, and 18 will take approximately 20 to 30 minutes.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/44 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - HIV uninfected - Sexually active - At risk for HIV (as determined by study officials) - Speaks English - Seen at a participating clinic Exclusion Criteria - Pregnant
Total Enrollment: 534
Location and Contact Information:
Overall Study Official:
PatriciaMorokoff, Principal Investigator, University of Rhode Island
Additional Information:
Study ID Numbers: R01 AI41323;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00080093
Other Hiv Infections Studies:
1. Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
2. A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
3. A Study of Indinavir Sulfate Given Together with Stavudine to HIV-Positive Patients
4. Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
5. A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
Related Studies:
Other HIV Infections Clinical Trials
Other Clinical Trials
Other Clinical Trials
Increasing Condom Use in People at Risk for HIV Infection
|
|
|
|
|
|
|
|
